Trending
Prev Story
Next Story

GLP-1 drugs could have a surprisingly large environmental payoff

Ars Technica •
November 22, 2026 • 12:07 PM
3
3 reads 0 reactions

GLP-1 drugs could cut food demand enough to free farmland larger than Italy.

GLP-1 drugs could have a surprisingly large environmental payoff

GLP-1 weight-loss medicines such as Ozempic and Wegovy could affect much more than the waistlines of the people who take them. If widely used, our new research suggests these appetite-suppressing medicines could transform the global food system and free up vast areas of agricultural land.

The global food system is ultimately driven by demand. If people eat less, producers respond, affecting production, prices, trade, and how much land is needed. We used a powerful computer simulation to explore scenarios ranging from GLP-1 use concentrated in high-income countries to widespread global access.

With widespread use of these medicines among adults living with obesity, we estimate that reduced calorie intake could prevent up to 6.6 million deaths each year by 2050, while freeing up as much as 32 million hectares of agricultural land—an area slightly larger than Italy—for other uses.

The biggest effects, however, occurred when reduced calorie intake was combined with a shift toward healthier diets. In this scenario, up to 7 million deaths could be avoided each year by 2050, while around 46 million hectares of agricultural land would have become available for other uses. This suggests that alongside weight-loss medicines, we need to make healthier options more widely available, affordable, and more appealing.

Food systems are interconnected across countries. If demand falls in one part of the world, this can affect farming, trade, and food prices elsewhere, with consequences for people who are not taking the medications at all.

Lower demand from GLP-1 users, for instance, could make food cheaper. That sounds positive, but cheaper food could also encourage greater consumption among non-users, offsetting some of the intended benefit. The effects of widespread GLP-1 use, in other words, cannot be understood just by looking at individual patients’ weight loss. They ripple through the global food system.

It’s tempting to read these findings as an argument for putting more people on weight-loss medication. That would miss the bigger picture.

Tags:
Prev Swipe Story Next

Same Story from Other Publications

Compare how 6 other independent news outlets reported on this story.

6 Publications
BBC News
1w ago
Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness

Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness

The US Food and Drug Administration says Ozempic, Wegovy, and other weight-loss drugs must have labels about the condition, known as NAION.

#glp #drugs
Compare →
CNBC World
1w ago
FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound

FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound

The agency has found evidence of a potential increased risk of a rare eye condition linked to the use of GLP-1 drugs used for weight management and diabetes.

#glp #drugs
Compare →
The Age
2d ago
First GLP-1 pills for weight loss go on sale in Australia

First GLP-1 pills for weight loss go on sale in Australia

Patients on lower doses of the new Wegovy pill will pay less than $10 a day.

CNN International
1w ago
Doctors explain GLP-1 side effects | CNN

Doctors explain GLP-1 side effects | CNN

Two doctors explain the big mistakes that cause GLP-1 side effects. Watch the full episode at CNN.com/BodyLanguage.

Sydney Morning Herald (SMH)
2w ago
‘Feeling really weak and shaky’: Experts warn of malnutrition risks on GLP-1s

‘Feeling really weak and shaky’: Experts warn of malnutrition risks on GLP-1s

Rapid weight loss can trigger hair loss, heart complications and vitamin deficiencies if nutrient needs go unmet, health experts have warned.

SBS News Australia
2w ago
A GLP-1 weight loss pill has been approved in Australia. Here's what we know

A GLP-1 weight loss pill has been approved in Australia. Here's what we know

The medication, traditionally used for diabetes, has been approved for weight management and cardiovascular concerns.

Related Stories

Technology
Build #2612